Expanding Opportunities for Women in Clinical Trials Leadership

Anne B. Curtis; Andrea M. Russo; Sana M. Al-Khatib

doi:10.1161/circulationaha.125.078127

Expanding Opportunities for Women in Clinical Trials Leadership

A Anne B. Curtis (Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, NY (A.B.C.).) A Andrea M. Russo (Department of Medicine, Cooper Medical School, Rowan University, Camden, NJ (A.M.R.).) S Sana M. Al-Khatib (Division of Cardiology, Duke University Medical Center, Durham, NC (S.M.A.-K.).)

View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Circulation

Volume / Issue Vol. 153, Issue 7

Published February 17, 2026

Pages 475-476

DOI 10.1161/circulationaha.125.078127

ISSN 0009-7322

Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (3)

A

Anne B. Curtis

Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, NY (A.B.C.).

A

Andrea M. Russo

Department of Medicine, Cooper Medical School, Rowan University, Camden, NJ (A.M.R.).

S

Sana M. Al-Khatib

Division of Cardiology, Duke University Medical Center, Durham, NC (S.M.A.-K.).

Expanding Opportunities for Women in Clinical Trials Leadership

Article Details

Journal Info

Authors (3)

Related Articles from this Journal

Occupational Radiation Safety in Electrophysiology During Pregnancy: Evaluating Uterine Radiation Doses During Catheter Ablations and Device Implantations

Response by Rogers et al to Letter Regarding, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”

Clinical Cardiology at the Crossroads: Perspectives on the Next Era at <i>Circulation</i>

ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction

Letter by Li et al Regarding Article, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”